PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsinfantile spasms
MeSH D013036 - infantile spasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004829:Generalized epilepsy
0 Companies
0 Drugs
Success rate
D000073376:Epileptic syndromes
$
Success rate
D013036: 
Infantile spasms
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaTopiramate Topiramate  2009-03-27   
Vigabatrin Vigabatrin  2019-01-14   
Glenmark PharmaceuticalsTopiramate Topiramate  2009-03-27   
NATCO PharmaTopiramate Topiramate  2009-03-27   
Johnson & JohnsonTopiramate Topamax  1996-12-24   
CiplaTopiramate Topiramate  2009-03-27   
Vigabatrin Vigabatrin  2019-12-03   
SanofiCorticotropin Acthar  1982-01-01   
Aurobindo PharmaTopiramate Topiramate  2009-03-27   
Vigabatrin Vigabatrin  2021-09-29   
Barr PharmaceuticalsTopiramate Topiramate  2009-03-27   
Dr Reddys LaboratoriesVigabatrin Vigabatrin  2018-11-20   
Topiramate Topiramate  2023-11-17   
Zydus TherapeuticsTopiramate Topiramate  2009-03-27   
Vigabatrin Vigabatrin  2023-03-02   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/1
Phase 2
46%
6/13
Phase 3
36%
4/11
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use